Trial Profile
Divalproex [valproate semisodium] ER [extended release] vs. risperidone for bipolar disorder with comorbid substance use disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Risperidone
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders; Substance-related disorders
- Focus Therapeutic Use
- 17 Dec 2005 New trial record.